DEVELOPMENT AND VALIDATION OF IMMUNOASSAY FOR IMMUNOGENICITY OF INTERFERON-ALPHA 2A DRUGS
Abstract
Interferons were one of the first groups of cytokines to be cloned and produced in bacteria. Interferon-based drugs are widely used for treatment of various infections, inflammatory and autoimmune diseases and malignant tumors. Clinical use of interferons can result in wide range of side effects, including unwanted influence on immune system of patients. Therefore it is important to study immunogenicity of interferones. The method of indirect ELISA was adopted and validated for analysis of antibodies to human recombinant interferon in mice blood plasma. The specificity was confirmed for mice antibodies. The linearity was 3.75-60.00 ng/ml, the detection limit was 2.19 ng/ml. Accuracy, interday and intraday precision did not exceed 15% at all concentration levels, that satisfies all validation requirements.
About the Authors
E. V. Mityushova
JSC «Institute of Experimental Pharmacology»
Russian Federation
Russian Federation
N. M. Faustova
JSC «SRA «House of Pharmacy»
Russian Federation
Russian Federation
O. N. Pozharitskaya
JSC «St.-Petersburg Institute of Pharmacy»
Russian Federation
Russian Federation
V. G. Makarov
JSC «St.-Petersburg Institute of Pharmacy»
Russian Federation
Russian Federation
A. N. Shikov
JSC «St.-Petersburg Institute of Pharmacy»
Russian Federation
Russian Federation
References
1. S.A. Stifter, C.G. Feng. Interfering with immunity: detrimental role of type I IFNs during infection // Journal of Immunology. 2015. V. 194. P. 2455-2465.
2. L. Grine, L. Dejager, C. Libert, R.E. Vandenbroucke. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17 // Cytokine & Growth Factor Reviews. 2015. V. 26. P. 25-33.
3. Ю.А. Вавиленкова. Современные представления о системе интерферона // Вестник Смоленской государственной медицинской академии. 2012. Т. 11(2). С. 74-82.
4. И.Г. Никитин. Пегилированные интерфероны-альфа: новые возможности лечения хронического гепатита С // Фарматека. 2002. Т. 9. С. 4.
5. I. Garcia, P.A. Prats, M. Cervantes et al. Factors that influence the immunogenicity of human recombinant interferon alpha-2b in mice // Biotechnologia Applicada. 2002. V. 19. P.15-18.
6. R.S. Yalow, S.A. Berson. Immunoassay of endogenous plasma insulin in man // Journal of Clinical Investigation. 1960. V.39. P. 1157-1175.
7. М. Тертон, Д.Р. Бангхем, К.А. Колкотт. Новые методы иммуноанализа. - М.: Мир. 1991. 280 c.
8. Иммунологические методы / Под ред. Г.Фримеля. - М.: Медицина. 1987. 472 с.
9. ELISA Instruction Manual (Cloud Clone Corp). URL: http://www.cloud-clone.us/manual/ELISA-Kit-for-Immunoglobulin-G-(IgG)-E90544Mu.pdf (Дата обращения 24.11.2015).
10. М.В. Шестакова, О.К. Викулова. Биосимиляры: презумпция «виновности» // Сахарный диабет. 2011. № 4. С. 91-99.
11. P. Tagliaferri, P. Tassone, S. Blotta et al. Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways // Cancer Immunology, Immunotherapy. 2005. V.54. P.1-10.
12. Directive 2010/63/EU of 22/09/2010 Guide for the care and use of laboratory animals 8th edition. National Academy of Sciences. Washington, D.C. 2010.
13. Руководство по валидации методик анализа лекарственных средств. - М.: Министерство здравоохранения и социального развития РФ. 2007. 49 с.
14. M. Deutsch, S.J. Hadziyannis. Old and emerging therapies in chronic hepatitis C: an update // Journal of Viral Hepatitis. 2008. V.15. P.2-11.
15. G.V. Papatheodoridis, S. Manolakopoulos, A.J. Archimandritis. Current treatment indications and strategies in chronic hepatitis B virus infection // World Journal of Gastroenterology. 2008. V.14. P.6902-6910.
16. Guidance for Industry: Bioanalytical method validation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evolution and Research (CDER). U.S. Government Printing Office: Washington, DC, 2001.
17. Валидация методов контроля химических и физико-химических показателей качества МИБП: порядок проведения и представления результатов. Методические указания. МУ 3.3.2.1886-04. 2004.
18. Н.В. Свежова, Д.Б. Шаркова, В.А. Громов и др. Методы математической обработки данных в иммуноферментном анализе // Клиническая лабораторная диагностика. 2008. №1. С. 3-9
19. А.М. Егоров, А.П. Осипов, Б.Б. Дзантиев, Е.М. Гаврилова. Теория и практика иммуноферментного анализа. - М.: Высшая школа. 1991. 288 с.
Review
For citations:
Mityushova E.V., Faustova N.M., Pozharitskaya O.N., Makarov V.G., Shikov A.N. DEVELOPMENT AND VALIDATION OF IMMUNOASSAY FOR IMMUNOGENICITY OF INTERFERON-ALPHA 2A DRUGS. Drug development & registration. 2017;(1):194-200. (In Russ.)
Views:
1311
Email this article 